These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 160042)

  • 1. Attenuation of the toxicity of a pyrrolizidine alkaloid (monocrotaline) by metabolic inhibition.
    Eisenstein D; Azari J; Huxtable R
    Proc West Pharmacol Soc; 1979; 22():193-8. PubMed ID: 160042
    [No Abstract]   [Full Text] [Related]  

  • 2. Monocrotaline-induced cardiopulmonary injury in rats: modification by thiol and nonthiol ACE inhibitors.
    Molteni A; Ward W; Ts'ao C; Solliday N
    Clin Exp Hypertens A; 1987; 9(2-3):381-5. PubMed ID: 3038399
    [No Abstract]   [Full Text] [Related]  

  • 3. Protective effects of butylated hydroxyanisole against the acute toxicity of monocrotaline in mice.
    Miranda CL; Reed RL; Cheeke PR; Buhler DR
    Toxicol Appl Pharmacol; 1981 Jul; 59(3):424-30. PubMed ID: 6791308
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparative effects of the pyrrolizidine alkaloids jacobine and monocrotaline on hepatic drug metabolising enzymes in the rat.
    Miranda CL; Cheeke PR; Buhler DR
    Res Commun Chem Pathol Pharmacol; 1980 Sep; 29(3):573-87. PubMed ID: 6775360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human liver microsomal reduction of pyrrolizidine alkaloid N-oxides to form the corresponding carcinogenic parent alkaloid.
    Wang YP; Yan J; Fu PP; Chou MW
    Toxicol Lett; 2005 Mar; 155(3):411-20. PubMed ID: 15649625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of steroidal and nonsteroidal microsomal enzyme inducers on the hepatotoxicity of pyrrolizidine alkaloids in rats.
    Tuchweber B; Kovacs K; Jago MV; Beaulieu T
    Res Commun Chem Pathol Pharmacol; 1974 Feb; 7(2):459-80. PubMed ID: 4818386
    [No Abstract]   [Full Text] [Related]  

  • 7. The role of flavin-containing monooxygenase in the N-oxidation of the pyrrolizidine alkaloid senecionine.
    Williams DE; Reed RL; Kedzierski B; Ziegler DM; Buhler DR
    Drug Metab Dispos; 1989; 17(4):380-6. PubMed ID: 2571476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monocrotaline pyrrole-induced cardiopulmonary toxicity is not altered by metergoline or ketanserin.
    Ganey PE; Sprugel KH; Hadley KB; Roth RA
    J Pharmacol Exp Ther; 1986 Apr; 237(1):226-31. PubMed ID: 2937908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dietary selenium status and pyrrolizidine alkaloid metabolism in vitro by rat liver microsomes.
    Shull LR; Buckmaster GW; Cheeke PR
    Res Commun Chem Pathol Pharmacol; 1977 Jun; 17(2):337-40. PubMed ID: 877417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of a low-lipotrope diet on the response of young male rats to the pyrrolizidine alkaloid, monocrotaline.
    Newberne PM; Wilson R; Rogers AE
    Toxicol Appl Pharmacol; 1971 Feb; 18(2):387-97. PubMed ID: 4105575
    [No Abstract]   [Full Text] [Related]  

  • 11. More light on pyrrolizidine alkaloids.
    Cooper P
    Food Cosmet Toxicol; 1979 Oct; 17(5):547-9. PubMed ID: 520986
    [No Abstract]   [Full Text] [Related]  

  • 12. Strain differences in pulmonary hypertensive response to monocrotaline alkaloid and the beneficial effect of oral magnesium treatment.
    Mathew R; Altura BT; Altura BM
    Magnesium; 1989; 8(2):110-6. PubMed ID: 2526910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro metabolism of isoline, a pyrrolizidine alkaloid from Ligularia duciformis, by rodent liver microsomal esterase and enhanced hepatotoxicity by esterase inhibitors.
    Tang J; Akao T; Nakamura N; Wang ZT; Takagawa K; Sasahara M; Hattori M
    Drug Metab Dispos; 2007 Oct; 35(10):1832-9. PubMed ID: 17639025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulmonary vasculature in monocrotaline-induced hypertensive rats on magnesium therapy.
    Mathew R; Gloster ES; Altura BT; Altura BM
    Microcirc Endothelium Lymphatics; 1990; 6(4-5):267-83. PubMed ID: 2149161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formation of DHP-derived DNA adducts from metabolic activation of the prototype heliotridine-type pyrrolizidine alkaloid, heliotrine.
    Xia Q; Yan J; Chou MW; Fu PP
    Toxicol Lett; 2008 May; 178(2):77-82. PubMed ID: 18395999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of 2(3)-tert-butyl-4-hydroxyanisole (BHA) and 2-chloroethanol against pyrrole production and chronic toxicity of monocrotaline in chickens.
    Dickinson JO; Braun RC
    Vet Hum Toxicol; 1987 Feb; 29(1):11-5. PubMed ID: 3103314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic activation of pyrrolizidine alkaloids by human, rat and avocado microsomes.
    Couet CE; Hopley J; Hanley AB
    Toxicon; 1996 Sep; 34(9):1058-61. PubMed ID: 8896199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioactivation and detoxication of the pyrrolizidine alkaloid senecionine by cytochrome P-450 enzymes in rat liver.
    Williams DE; Reed RL; Kedzierski B; Dannan GA; Guengerich FP; Buhler DR
    Drug Metab Dispos; 1989; 17(4):387-92. PubMed ID: 2571477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic activation of the tumorigenic pyrrolizidine alkaloid, monocrotaline, leading to DNA adduct formation in vivo.
    Wang YP; Yan J; Beger RD; Fu PP; Chou MW
    Cancer Lett; 2005 Aug; 226(1):27-35. PubMed ID: 16004930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum copper concentration as an index of cardiopulmonary injury in monocrotaline-treated rats.
    Molteni A; Ward WF; Ts'ao CH; Fitzsimons EJ
    Ann Clin Lab Sci; 1988; 18(6):476-83. PubMed ID: 3149170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.